{"id":"https://openalex.org/W2106436765","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1663","title":"Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216","display_name":"Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W2106436765","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1663","mag":"2106436765","pmid":"https://pubmed.ncbi.nlm.nih.gov/24240111"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-13-1663","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1663","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-1663","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/20/3/631/2022626/631.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/20/3/631/2022626/631.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026543504","display_name":"Marlena Walls","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marlena Walls","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010409591","display_name":"Sangita M. Baxi","orcid":"https://orcid.org/0000-0001-9476-3831","observed_orcids":["https://orcid.org/0000-0001-9476-3831"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sangita M. Baxi","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051851544","display_name":"Pramod P. Mehta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pramod P. Mehta","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090938018","display_name":"Kevin K.\u2010C. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin K.-C. Liu","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103857633","display_name":"JinJiang Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JinJiang Zhu","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034065188","display_name":"Heather Estrella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Estrella","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085929266","display_name":"Chunze Li","orcid":"https://orcid.org/0000-0002-8906-6553","observed_orcids":["https://orcid.org/0000-0002-8906-6553"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chunze Li","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030528038","display_name":"Michael A. Zientek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Zientek","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967094","display_name":"Qing Zong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qing Zong","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004738391","display_name":"Tod Smeal","orcid":"https://orcid.org/0009-0000-0320-7451","observed_orcids":["https://orcid.org/0009-0000-0320-7451"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tod Smeal","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103416325","display_name":"Min-Jean Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Min-Jean Yin","raw_affiliation_strings":["Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","Computational Biology","Medicinal Chemistry","Pharmacokinetics, Dynamics, and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Oncology Research Unit; 2Medicinal Chemistry; 3Computational Biology; 4Pharmacokinetics, Dynamics, and Metabolism; and 5Drug Safety, Pfizer Worldwide Research and Development, San Diego, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Computational Biology","institution_ids":[]},{"raw_affiliation_string":"Medicinal Chemistry","institution_ids":[]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics, and Metabolism","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103416325"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":null,"apc_paid":null,"fwci":1.3432,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.80217066,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"20","issue":"3","first_page":"631","last_page":"643"},"is_retracted":true,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.05220000073313713,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.7379999756813049},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9139999747276306},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.7699999809265137},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.6190000176429749},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7429999709129333},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.5669999718666077}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.8663050532341003},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7487289309501648},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7092164158821106},{"id":"https://openalex.org/C2781465904","wikidata":"https://www.wikidata.org/wiki/Q14887700","display_name":"P110\u03b1","level":4,"score":0.6091036796569824},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5965389609336853},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5166483521461487},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5010056495666504},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.49013885855674744},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4529399871826172},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4454701840877533},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41106587648391724},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3449539840221405},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2336769998073578},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07065001130104065}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015151","descriptor_name":"Immunoblotting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055752","descriptor_name":"Small Cell Lung Carcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-13-1663","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1663","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-1663","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/20/3/631/2022626/631.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:24240111","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24240111","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-13-1663","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1663","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-1663","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/20/3/631/2022626/631.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.800000011920929,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2106436765.pdf","grobid_xml":"https://content.openalex.org/works/W2106436765.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W19457734","https://openalex.org/W237683375","https://openalex.org/W1966133006","https://openalex.org/W1973996451","https://openalex.org/W1981711832","https://openalex.org/W1982395176","https://openalex.org/W1982475443","https://openalex.org/W1984621921","https://openalex.org/W1990676527","https://openalex.org/W1998836974","https://openalex.org/W2015833202","https://openalex.org/W2017739035","https://openalex.org/W2024085992","https://openalex.org/W2025572630","https://openalex.org/W2034691869","https://openalex.org/W2039258567","https://openalex.org/W2042994628","https://openalex.org/W2043398720","https://openalex.org/W2043865307","https://openalex.org/W2056631765","https://openalex.org/W2068326740","https://openalex.org/W2075827435","https://openalex.org/W2079977894","https://openalex.org/W2080100938","https://openalex.org/W2091134276","https://openalex.org/W2091347388","https://openalex.org/W2091554746","https://openalex.org/W2092045274","https://openalex.org/W2108401385","https://openalex.org/W2114725617","https://openalex.org/W2116091236","https://openalex.org/W2117026649","https://openalex.org/W2117263216","https://openalex.org/W2117986690","https://openalex.org/W2119855881","https://openalex.org/W2124593509","https://openalex.org/W2125790469","https://openalex.org/W2132099317","https://openalex.org/W2137297899","https://openalex.org/W2139810669","https://openalex.org/W2146414563","https://openalex.org/W2146983373","https://openalex.org/W2165404212","https://openalex.org/W2589396808","https://openalex.org/W6600778320"],"related_works":["https://openalex.org/W2330239550","https://openalex.org/W2018771406","https://openalex.org/W2465500123","https://openalex.org/W2071596420","https://openalex.org/W2116091236","https://openalex.org/W2113548725","https://openalex.org/W2741276476","https://openalex.org/W2896055861","https://openalex.org/W1997232290","https://openalex.org/W2157958054"],"abstract_inverted_index":{"PURPOSE:":[0],"Constitutive":[1],"activation":[2],"of":[3,22,27,97],"phosphoinositide":[4],"3-kinase":[5],"(PI3K)":[6],"occurs":[7],"frequently":[8],"in":[9,17,51,69,111,113,134,142,173,181,222],"many":[10],"human":[11],"tumors":[12],"via":[13],"either":[14],"gene":[15],"mutation":[16,103,226,248],"the":[18,62,77,148],"p110\u03b1":[19],"catalytic":[20],"subunit":[21],"PI3K":[23,66,78,117,162,194],"or":[24,104,212],"functional":[25],"loss":[26,106],"tumor":[28,152,179],"suppressor":[29],"PTEN.":[30],"Patients":[31],"with":[32,101,109,188,244,246],"small-cell":[33],"lung":[34],"cancer":[35,239],"(SCLC)":[36],"have":[37],"very":[38],"poor":[39],"prognosis":[40],"and":[41,125,151,165,171,177,219],"survival":[42],"rates":[43],"such":[44],"that":[45,88,131,234],"an":[46,81],"effective":[47,82],"targeted":[48,83],"therapy":[49,84],"is":[50,80,236],"strong":[52],"demand":[53],"for":[54,86,242],"these":[55],"patients.":[56],"In":[57,186],"this":[58],"study,":[59],"we":[60],"characterized":[61],"highly":[63],"selective":[64],"oral":[65],"inhibitor,":[67],"PF-4989216,":[68],"preclinical":[70],"SCLC":[71,98,128,245],"models":[72],"to":[73,136,146,168],"investigate":[74],"whether":[75],"targeting":[76],"pathway":[79,118],"option":[85],"SCLCs":[87,182,187,223],"harbor":[89],"a":[90,237],"PIK3CA":[91,102,184,225,247],"mutation.":[92,185],"EXPERIMENTAL":[93],"DESIGN:":[94],"A":[95],"panel":[96],"cell":[99,120,126,129,174,210],"lines":[100,130],"PTEN":[105,189,228,251],"were":[107,132,138],"treated":[108],"PF-4989216":[110,137,157,160,191,235],"several":[112],"vitro":[114,135],"assays,":[115],"including":[116],"signaling,":[119],"viability,":[121,175],"apoptosis,":[122],"cell-cycle":[123],"progression,":[124],"transformation.":[127,213],"sensitive":[133],"further":[139],"evaluated":[140],"by":[141,156],"vivo":[143],"animal":[144],"studies":[145],"determine":[147],"pharmacokinetic/pharmacodynamic":[149],"relationship":[150],"growth":[153,180],"inhibition":[154,172],"(TGI)":[155],"treatment.":[158],"RESULTS:":[159],"inhibited":[161,193],"downstream":[163],"signaling":[164,195],"subsequently":[166],"led":[167],"apoptosis":[169,203,220],"induction,":[170],"transformation,":[176],"xenograft":[178],"harboring":[183,224],"loss,":[190],"also":[192],"but":[196,249],"did":[197],"not":[198,250],"induce":[199],"BCL2-interacting":[200],"mediator":[201],"(BIM)-mediated":[202],"nor":[204],"was":[205],"there":[206],"any":[207],"effect":[208],"on":[209],"viability":[211],"These":[214],"results":[215,232],"implicate":[216],"differential":[217],"tumorigenesis":[218],"mechanisms":[221],"versus":[227],"loss.":[229,252],"CONCLUSIONS:":[230],"Our":[231],"suggest":[233],"potential":[238],"drug":[240],"candidate":[241],"patients":[243]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}